Janagliflozin Uses, Dosage, Side Effects and more
Janagliflozin is under investigation in clinical trial NCT03851432 (Janagliflozin Treat Type 2 Diabetes Mellitus (T2DM) Inadequately Controlled With Metformin).
| Trade Name | Janagliflozin |
| Generic | Janagliflozin |
| Type | |
| Formula | C25H29ClO6 |
| Weight | Average: 460.95 Monoisotopic: 460.1652664 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
